Literature DB >> 10631905

Early detection of esophageal squamous cell carcinoma and its effects on therapy: an overview.

L Q Chen1, C Y Hu, P Ghadirian, A Duranceau.   

Abstract

Squamous cell carcinoma of the esophagus shows a wide variation in incidence worldwide. It is the fifth leading cause of cancer-related death in men and usually diagnosed at an advanced stage with unsatisfactory therapeutic results. The techniques available for early detection of esophageal carcinoma are reviewed in this paper, as well as its overall effect on survival. For the time being, only surgical resection at a very early stage may improve survival of the disease. Esophageal cancer can be treated at an earlier stage when it is diagnosed by mass screening detection. However, despite a high survival rate at 5 years, local recurrences and distal metastases may still occur even 10 years after treatment. Prevention and therapeutic intervention at an earlier stage before the oncologic process has resulted in cancer changes is necessary to alter the natural evolution of the disease.

Entities:  

Mesh:

Year:  1999        PMID: 10631905     DOI: 10.1046/j.1442-2050.1999.00039.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  12 in total

1.  Anaphylatoxin C3a: A potential biomarker for esophageal cancer diagnosis.

Authors:  Xu Zhang; Lingzhi Sun
Journal:  Mol Clin Oncol       Date:  2017-12-06

2.  PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.

Authors:  Keisuke Kurimoto; Masamichi Hayashi; Rafael Guerrero-Preston; Masahiko Koike; Mitsuro Kanda; Sho Hirabayashi; Hiroshi Tanabe; Nao Takano; Naoki Iwata; Yukiko Niwa; Hideki Takami; Daisuke Kobayashi; Chie Tanaka; Suguru Yamada; Goro Nakayama; Hiroyuki Sugimoto; Tsutomu Fujii; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Epigenetics       Date:  2017-11-27       Impact factor: 4.528

Review 3.  Evaluation of preoperative staging for esophageal squamous cell carcinoma.

Authors:  Lin-Na Luo; Long-Jun He; Xiao-Yan Gao; Xin-Xin Huang; Hong-Bo Shan; Guang-Yu Luo; Yin Li; Shi-Yong Lin; Guo-Bao Wang; Rong Zhang; Guo-Liang Xu; Jian-Jun Li
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

4.  Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.

Authors:  Jian Zhang; Jeremiah Bowers; Lingyan Liu; Siwei Wei; G A Nagana Gowda; Zane Hammoud; Daniel Raftery
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

5.  Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in patients with dyspepsia in a GI clinic: a 7-year cross-sectional study.

Authors:  Hooman Khademi; Amir-Reza Radmard; Fatemeh Malekzadeh; Farin Kamangar; Siavosh Nasseri-Moghaddam; Mattias Johansson; Graham Byrnes; Paul Brennan; Reza Malekzadeh
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

Review 6.  The potential of molecular markers to improve interventions through the natural history of oesophageal squamous cell carcinoma.

Authors:  Nathalia Meireles da Costa; Sheila Coelho Soares Lima; Tatiana de Almeida Simão; Luis Felipe Ribeiro Pinto
Journal:  Biosci Rep       Date:  2013-08-14       Impact factor: 3.840

Review 7.  Early squamous neoplasia of the esophagus: The endoscopic approach to diagnosis and management.

Authors:  Kesavan Kandiah; Fergus J Q Chedgy; Sharmila Subramaniam; Sreedhari Thayalasekaran; Arun Kurup; Pradeep Bhandari
Journal:  Saudi J Gastroenterol       Date:  2017 Mar-Apr       Impact factor: 2.485

8.  The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma.

Authors:  George Couch; James E Redman; Lorenz Wernisch; Richard Newton; Shalini Malhotra; Sanford M Dawsey; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  Cancer Prev Res (Phila)       Date:  2016-04-12

9.  Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.

Authors:  Kun Jia; Wei Li; Feng Wang; Haixia Qu; Yuanyuan Qiao; Lanping Zhou; Yulin Sun; Qingwei Ma; Xiaohang Zhao
Journal:  Oncotarget       Date:  2016-04-26

10.  The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death.

Authors:  Wei Li; Guixue Hou; Dianrong Zhou; Xiaomin Lou; Yang Xu; Siqi Liu; Xiaohang Zhao
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.